ARTICLE | Financial News
Anadys planning follow-on
October 15, 2010 12:45 AM UTC
Anadys Pharmaceuticals Inc. (NASDAQ:ANDS) said late Thursday it is planning a follow-on underwritten by Lazard. Further details were not disclosed. Anadys' ANA598, an oral non-nucleoside NS5B polymera...